Lab-on-a-chip systems for cancer biomarker diagnosis
MetadataShow full item record
CitationÖzyurt, C., Uludağ, İ., İnce, B., & Sezgintürk, M. K. (2023). Lab-on-a-chip systems for cancer biomarker diagnosis. Journal of Pharmaceutical and Biomedical Analysis, 226, 115266. https://doi.org/10.1016/j.jpba.2023.115266
Lab-on-a-chip (LOC) or micro total analysis system is one of the microfluidic technologies defined as the adaptation, miniaturization, integration, and automation of analytical laboratory procedures into a single instrument or “chip”. In this article, we review developments over the past five years in the application of LOC biosensors for the detection of different types of cancer. Microfluidics encompasses chemistry and biotechnology skills and has revolutionized healthcare diagnosis. Superior to traditional cell culture or animal models, microfluidic technology has made it possible to reconstruct functional units of organs on chips to study human diseases such as cancer. LOCs have found numerous biomedical applications over the past five years, including integrated bioassays, cell analysis, metabolomics, drug discovery and delivery systems, tissue and organ physiology and disease modeling, and personalized medicine. This review provides an overview of the latest developments in microfluidic-based cancer research, with pros, cons, and prospects.